NCT06846021

Integral Single-cell Landscape of Immunological Hallmarks for Ankylosing Spondylitis

Single-cell Immunomics Research on the Onset and Different Outcomes in Patients with Ankylosing Spondylitis

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 17 (actual)
• Sponsor: Fujian Provincial Hospital · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Accepted

Summary

Three HLA-B27-positive health donors (HDs) with matching age were enrolled via genetic screening, and fourteen AS patients were recruited at Fujian provincial hospital from May to July 2021. All AS patients satisfied the modified New York (NY) criteria, and the categorization of three disease groups (EA, LD and RM) was according to clinical hallmarks and imaging evidences. The five patients in the EA group were in the early stage of disease, showing obvious symptoms, and had not yet received standard treatments, including various NSAIDs and DMARDs. The five patients in the LD group were all disabled, and confirmed by radiographic evidence of structural damage in hip joints and spinal deformity. The four patients in the RM group received standardized treatment under the guidance of specialist doctors, and maintained clinical remission and normal laboratory indicators for over six months. Patients in both EA and RM groups were confirmed to have no structural damage or deformities by radiographic evidences.

Conditions

• Ankylosing Spondylitis

Interventions

Type	Name	Description
OTHER	Disease status	According to the disease status, patients are divided into four groups including healthy donors, initial patients with high activity, patients with deformities and patients with clinical remission

Timeline

• Start date: 2021-05-17
• Primary completion: 2021-06-30
• Completion: 2021-08-25
• First posted: 2025-02-25
• Last updated: 2025-03-04

Locations

1 site across 1 country: China